Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook

Go back to Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook

Quest Diagnostics (DGX) PT Raised to $115 at Deutsche Bank

April 21, 2017 8:26 AM EDT

Deutsche Bank raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $108.00) while maintaining a Buy rating.

... More

Quest Diagnostics (DGX) PT Raised to $104.50 at Evercore ISI

April 20, 2017 1:03 PM EDT

Evercore ISI raised its price target on Quest Diagnostics (NYSE: DGX) to $104.50 (from $102.00) while maintaining an In Line rating.

Analyst Ross Muken said DGX has become one of the most consistent companies in healthcare. That said, valuation keeps them on the... More

Quest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook

April 20, 2017 6:47 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.33, $0.15 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.87 billion.

"We delivered strong growth across the board in the first quarter with gains in revenues,... More